Larimar Therapeutics (LRMR) Change in Cash (2013 - 2025)

Larimar Therapeutics' Change in Cash history runs 13 years deep, the most recent figure standing at -$4.7 million for Q4 2025.

• Quarterly Change in Cash fell 83.11% year-over-year to -$4.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $52.2 million (up 809.94% YoY) and the FY2025 annual result came in at $52.2 million, up 809.94% from the prior year.
• Change in Cash was -$4.7 million for Q4 2025 at Larimar Therapeutics, down from $69.6 million in the prior quarter.
• Across five years, Change in Cash topped out at $84.7 million in Q1 2023 and bottomed at -$77.8 million in Q2 2024.
• A 5-year average of $826550.0 and a median of -$3.7 million in 2024 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2021 — Change in Cash sank 4781.15% — and 2022, when it surged 7309.05%.
• Larimar Therapeutics' Change in Cash stood at -$1.4 million in 2021, then slumped by 4047.2% to -$59.2 million in 2022, then jumped by 79.78% to -$12.0 million in 2023, then jumped by 78.43% to -$2.6 million in 2024, then sank by 83.11% to -$4.7 million in 2025.
• Business Quant data shows LRMR's Change in Cash at -$4.7 million in Q4 2025, $69.6 million in Q3 2025, and -$539000.0 in Q2 2025.